Earnings Summary: Quest Diagnostics (DGX) reaffirms FY25 guidance

[ad_1] Quest Diagnostics Incorporated (NYSE: DGX), a provider of diagnostic information services, has reaffirmed its outlook for fiscal 2025 and provided cautious first-quarter guidance. Quest said it continues to expect full-year 2025 net revenue to be in the range of…








